Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 4,297 | 1,509 | 2,231 | 2,781 | 1,458 |
| Operating Income | -4,297 | -1,509 | -2,231 | -2,781 | -1,458 |
| Other Income | 148 | -845 | 2 | 5 | -2 |
| Pre-tax Income | -4,149 | -2,354 | -2,229 | -2,776 | -1,460 |
| Net Income Continuous | -4,149 | -2,354 | -2,229 | -2,776 | -1,460 |
| Net Income | $-4,149 | $-2,354 | $-2,229 | $-2,776 | $-1,460 |
| EPS Basic Total Ops | 402.26 | -9.54 | -0.08 | -449.58 | 316.97 |
| EPS Basic Continuous Ops | 554.50 | -9.53 | -139.32 | -462.62 | 349.71 |
| EPS Diluted Total Ops | 402.26 | -9.54 | -0.08 | -449.58 | 316.97 |
| EPS Diluted Continuous Ops | 554.50 | -9.53 | -139.32 | -462.62 | 349.71 |
| EPS Diluted Before Non-Recurring Items | -9.40 | -5.85 | -139.86 | N/A | N/A |
| EBITDA(a) | $-4,250 | $-1,455 | $-2,181 | $-2,725 | $-1,397 |